News Search

Author: Samantha Savello

PCI Fellows’ Meeting

The PCI Fellows had a lovely potluck at Tomas’s house in January. They shared their latest news, brought great food to share, and even had piano performances by Max and Dora.

Penn Scientists New Research Shows That a CAR-T gel Treatment May Be Able to Kill Residual Cancer Cells Left Over from Surgery

In the study, Penn scientists added CAR-T cells to a gel designed to prevent bleeding after surgery and applied it to the surgical wounds of mice after they had hard-to-treat tumors resected.

PCI Hosts its 7th Annual Innovation@Penn Conference

On January 9th, 2023 PCI was proud to present a star-studded program entitled “The Future of mRNA Technology” at Wharton San Francisco during the JP Morgan Healthcare Conference.

Karikó and Weissman named to the National Inventors Hall of Fame

Karikó and Weissman were named to the National Inventors Hall of Fame for their mRNA research which made covid-19 vaccines possible.

Penn I-Corps Fall 2022 Cohort 

In Fall 2022, ten teams participated in the Penn I-Corps Program, representing the Schools of Arts and Sciences, Engineering, Medicine, Veterinary Medicine, and Business.

Penn Startups Raising Money in 2023

There are a wide range of Penn spinouts across industries that are working on innovative and transformative products and projects. This is a list of Penn startups currently raising money in 2023.

Penn’s Abramson Cancer Center Presents New Cancer Research at 2022 American Society of Hematology (ASH) Annual Meeting

Researchers from Penn’s Abramson Cancer Center presented the preliminary results of an ongoing Phase I clinical trial for a novel CAR T therapy to be used after cancer.

Penn Researchers Work On Reducing CO2 Emissions by Repurposing Waste from Industrial Mines

Peter Psarras, a research assistant professor in chemical and biomolecular engineering, and his colleagues are repurposing waste from industrial mines.

Penn spinout Peroxitech raises $25M to advance novel drug to treat acute lung injury

Penn spinout Peroxitech raised $25M to further develop its novel drug candidate, PIP-2.


Skip to content